Summary for Clinicians: Clinical Practice Guideline for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations

Affiliations

• ¹ Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University Langone Health, New York, New York.
• ² Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts.
• ³ Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
• ⁴ Division of Pulmonary and Critical Care, Department of Medicine, Mount Auburn Hospital/Beth Israel Lahey Health, Cambridge, Massachusetts.
• ⁵ Division of Pulmonary and Critical Care, Department of Medicine, Harvard Medical School, Boston, Massachusetts.
• ⁶ American Thoracic Society, New York, New York.
• ⁷ Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
• ⁸ ZS Associates, Global Health Economics and Outcomes Research, New York, New York; and.
• ⁹ Center for Interstitial Lung Diseases, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine and Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.